Lung biopsies for interstitial lung disease: The limits of the traditional methods of microbiological identification

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 1, 2012, Pages 39-40

  D'Journo, Xavier Benoit ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Cytomegalovirus; Interstitial lung disease; Lung biopsy; Microbiological analysis; Pneumonia; Surgery

Indexed keywords

RIBOSOME RNA;

BACTERIUM CULTURE; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; FIBROSING ALVEOLITIS; FUNGUS CULTURE; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; IMMUNE SYSTEM; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG INFECTION; MICROBIOLOGICAL EXAMINATION; NOTE; PLEURISY; PRIORITY JOURNAL; VIRUS CULTURE; FEMALE; LUNG; MALE; MICROBIOLOGY; RESPIRATORY TRACT INFECTION;

FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; RESPIRATORY TRACT INFECTIONS;

EID: 84860338995     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.04.009     Document Type: Note

References (10)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-64.
2. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, Hirani N, Hubbard R, Lake F, Millar AB, Wallace WA, Wells AU, Whyte MK, Wilsher ML, British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee, Thoracic Society of Australia, New Zealand Thoracic Society, Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008;63:1-58.
3. Fibla JJ, Brunelli A, Allen M, Wigle D, Shen R, Nichols F, Deschamps C, Cassivi SD. Microbiology specimens obtained at the time of surgical lung biopsy for interstitial lung disease: clinical yield and cost analysis. Eur J Thorac Cardiovasc Surg 2012;41:36-8.
4. Vanfleteren LE, Linssen CF. Role of microorganisms in interstitial lung disease. Curr Opin Pulm Med 2010;16:489-95.
5. Pace NR. A molecular view of microbial diversity and the biosphere. Science 1997;276:734-40.
6. Bittar F, Rolain JM. Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients. Clin Microbiol Infect 2010; 16:809-20.
7. Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006;174: 817-23.
8. Menéndez R, Córdoba J, de La Cuadra P, Cremades MJ, López-Hontagas JL, Salavert M, Gobernado M. Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia. Am J Respir Crit Care Med 1999;159: 1868-73.
9. Bittar F, Richet H, Dubus JC, Reynaud-Gaubert M, Stremler N, Sarles J, Raoult D, Rolain JM. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS One 2008;3:e2908.
10. Vassallo R. Viral-induced inflammation in interstitial lung diseases. Semin Respir Infect 2003;18:55-60.